: The top-performing stock in the S&P 500 for 2017, rising 121% . Its turnaround was fueled by a restructuring plan and a shift in investor sentiment toward utility companies.
The top of the leaderboard was dominated by small-to-mid-cap biotechnology firms that saw astronomical returns following clinical trial successes or major partnerships.
: Returned 373% after receiving FDA approval for its hepatitis B vaccine.
The year 2017 was a landmark year for equity markets, characterized by a massive surge in and semiconductors . While the tech giants of the "FANG" era (Facebook, Amazon, Netflix, Google) continued to post impressive gains, the true "breakout" stories came from specialized medical research and the chips powering the digital revolution. The Best Performing Stocks of 2017
Copyright © 2011-2025 冰楓論壇, All rights reserved
免責聲明：本網站是以即時上載留言的方式運作，本站對所有留言的真實性、完整性及立場等，不負任何法律責任。
而一切留言之言論只代表留言者個人意見，並非本網站之立場，用戶不應信賴內容，並應自行判斷內容之真實性。
